Syndicated data provider Symphony Health Solutions to offer weekly views of prescription activity

HORSHAM, Pa. — Symphony Health Solutions last week announced it now offers weekly views of pharmaceutical sales and prescription activity. The company launched PHAST 2.0 Institutional Weekly and PHAST 2.0 Integrated Weekly, weekly audits of U.S. institutional sales and overall market activity.

“These new weekly audits allow us to provide the most comprehensive and timely coverage of both retail prescription activity and non-retail sales,” said Don Otterbein, SVP product management and marketing, Symphony Health Solutions. “Given the rate and pace of change in the healthcare and life sciences markets, it is increasingly important for our clients to have timely and actionable market intelligence to compete effectively.”

Previously available only on a monthly basis, the two new audits give customers more timely access to institutional and prescription market data. Pharmaceutical manufacturers and financial analysts can use the data to monitor drug launches and the activity of competitive drugs in the marketplace. In addition, the integrated audit has been enhanced with additional data on specialty drugs in a number of areas including oncology, rheumatoid arthritis and HIV. 

PHAST 2.0 Integrated Weekly gives a combined view of retail pharmacy activity together with non-retail institutional sales to provide a comprehensive view of the market, SHS reported. PHAST 2.0 Institutional Weekly offers a view of pharmaceutical product sales to institutions, such as hospitals, clinics and long-term care facilities.